Plenary session Digital GU Debates
20 October 2020 - 51 Minutes

Plenary session Digital GU Debates

The meeting will be focused on current challenges and recent advances in the management of GU cancers and on how we can improve the lives of those we treat by focusing on aspects such as the psychological and physical impact of treatments or on the patient support network. Moreover, if you register for this event, you will receive a confirmation ...

more info...

EM-30025
Breakout 1: The impact of PC treatment: bone health and the management of pain and fatigue
20 October 2020 - 29 Minutes

Breakout 1: The impact of PC treatment: bone health and the management of pain and fatigue

Learning objective:         

After watching this broadcast, participants should be able to:

  • Describe strategies for managing pain, fatigue and bone health in patients with PC and reflect on how these strategies can be integrated into clinical practice

 

Faculty:

  • Daniele Santini (Italy)
  • Joe O’Sullivan (UK)
more info...

EM-45810
Breakout 2: Bladder cancer in women: key differences and challenges 
20 October 2020 - 39 Minutes

Breakout 2: Bladder cancer in women: key differences and challenges 

Learning objective:         

After watching this broadcast, participants should be able to:

  • Discuss the challenges faced in managing bladder cancer in women and reflect on the importance of early diagnosis and testing in the management of patients with BC.

 

Faculty:

  • Maria De Santis (Germany)
  • Alison Birtle (UK)
more info...

EM-45810
Breakout 3: Sexual function in patients with GU cancers: difficult conversations and emotional impact
20 October 2020 - 40 Minutes

Breakout 3: Sexual function in patients with GU cancers: difficult conversations and emotional impact

Learning objective:         

After watching this broadcast, participants should be able to:

  • Discuss the impact of GU cancers on sexual function and define strategies to mitigate this burden.

 

Faculty:

  • Woet L. Gianotten (The Netherlands)
  • Catherine Hood (UK)
more info...

EM-45810
Breakout 4: What do we talk about when we talk about the patient support network?
20 October 2020 - 31 Minutes

Breakout 4: What do we talk about when we talk about the patient support network?

Learning objective:         

After watching this broadcast, participants should be able to:

  • Identify and explain the importance of the patient support network in the management of patients with GU cancers.

 

Faculty:

  • Alvaro Pinto (UK)
  • Lawrence Drudge-Coates (UK)
more info...

EM-45810
Breakout 5: What does quality of life mean? Patient and clinician perspectives
20 October 2020 - 30 Minutes

Breakout 5: What does quality of life mean? Patient and clinician perspectives

Learning objective:         

After watching this broadcast, participants should be able to:

  • Compare tools that can be used to assess the quality of life of patients with GU cancers and apply these tools in clinical practice.

 

Faculty:

  • Bertrand Tombal (Belgium)
  • Alicia Morgans (USA)
more info...

EM-45810
Breakout 6: Managing polypharmacy & comorbidities in prostate cancer and bladder cancer
20 October 2020 - 36 Minutes

Breakout 6: Managing polypharmacy & comorbidities in prostate cancer and bladder cancer

Learning objective:         

After watching this broadcast, participants should be able to:

  • Analyse the impact of comorbidities and subsequent polypharmacy on subsequent decision making in the management of prostate cancer and bladder cancer.

 

Faculty:

  • Romano Danesi (Italy)
  • Ignacio Duran (Spain)
  • Heather Payne (UK)
more info...

EM-45810
ON-DEMAND webinar: Intrinsic and acquired resistance to EGFR TKIs: new therapies on the horizon
30 September 2020 - 123 Minutes

ON-DEMAND webinar: Intrinsic and acquired resistance to EGFR TKIs: new therapies on the horizon

Learning objectives:         

After attending this symposium, participants should be able to:

  • Highlight the importance of intrinsic and acquired EGFR resistance mutations in NSCLC and how this can impact patient outcomes
  • Understand the increasing role of genetic and molecular profiling and biomarkers in tailoring therapy
  • Describe how current and future research in the ...
more info...

EM-39341
ON-DEMAND webinar: Advanced prostate cancer – how do we move forward in patient management?
30 September 2020 - 156 Minutes

ON-DEMAND webinar: Advanced prostate cancer – how do we move forward in patient management?

Learning objectives:         

After attending this symposium, participants should be able to:

  • Review the current management strategies for metastatic hormone-sensitive prostate cancer (mHSPC) to optimise patient care
  • Discuss the impact of new data on treatment and management decisions forindividual patients with non-metastatic castration-resistant prostate cancer(nmCRPC) and metastatic castration-resistant prostate cancer (mCRPC)
  • Describe considerations ...
more info...

EM-39340
Bladder cancer news September 2020: an expert view
23 September 2020 - 1 Hours

Bladder cancer news September 2020: an expert view

Learning objective:         

After attending this meeting, participants should be able to:

  • Discuss and explain the new data on bladder cancer
  • Integrate the discussed data into the current bladder cancer landscape

 

Scientific Committee:

  • Alison Birtle (UK)
  • Ignacio Duran (Spain)

 

Faculty:

  • Morgan Roupret (France)
  • Yohann Loriot (France)
more info...

EM-39337